Le Lézard
Classified in: Health
Subjects: MAV, FVT, CFG

Media Advisory - Member of Parliament Gordie Hogg to highlight gambling addiction research at the University of British Columbia


VANCOUVER, Feb. 20, 2018 /CNW/ - Gordie Hogg, MP for South Surrey?White Rock, will visit the University of British Columbia to highlight a recent investment in gambling addiction research, tour its research facilities, and meet with health researchers.  

Media are invited to join the tour and participate in a media availability with MP Hogg and health researchers.  

 

Date:

February 21, 2018

Time:

1:00 p.m.

Location:

Centre for Gambling Research at UBC

4th Floor ? Audain Art Centre

University of British Columbia

6398 University Boulevard

Vancouver, B.C. V6T 1Z4

                       

SOURCE Canadian Institutes of Health Research


These press releases may also interest you

at 07:40
Global Weight Loss Drugs Markets Report 2023-2024 & 2029 - The Emergence of GLP-1 and GIP, Unmet Market Needs and Emerging Product Pipeline - ResearchAndMarkets.com
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:35
Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...

at 07:35
AbbVie Reports First-Quarter 2024 Financial Results
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share Related to Acquired IPR&D and...

at 07:30
INTEGRAcare Inc. has been named as #1 Best Workplace in Healthcare in Canada & the 5th Best Workplace in Canada (across all industries) in 2024 by Great Place to Work®
During an awards ceremony to present the 2024 list of Best Workplacestm in Canada, Great Place to Work® announced the 50 Best Workplacestm in Canada with 100-999 employees....

at 07:05
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and other infectious disease assays. Simplifying...

at 07:00
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
Bristol Myers Squibb today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Opdivo® (nivolumab) in combination with cisplatin and gemcitabine for the...

More news about Health...


News published on and distributed by: